Saya L. Jacob

Oncology
3400 Civic Center Boulevard
West Pavilion, 3rd Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Incidence, Risk Factors, and Survival Implications of Immune-Related Adverse Events in Patients With Metastatic Breast Cancer.

Incidence, Risk Factors, and Survival Implications of Immune-Related Adverse Events in Patients With Metastatic Breast Cancer.

Journal: Clinical breast cancer
Published: March 20, 2026

Multi-institutional analysis of incidence and risks for late-onset immune toxicity in breast cancer.

Multi-institutional analysis of incidence and risks for late-onset immune toxicity in breast cancer.

Journal: NPJ breast cancer
Published: May 05, 2025

Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC).

Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC).

Journal: NPJ breast cancer
Published: November 16, 2024

Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy.

Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy.

Journal: Breast cancer research and treatment
Published: April 30, 2024

Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA.

Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 18, 2024

Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response.

Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response.

Journal: BJC reports
Published: January 04, 2024

Crofelemer for the Management of Neratinib-Associated Diarrhea in Patients With HER2+ Early-Stage Breast Cancer.

Crofelemer for the Management of Neratinib-Associated Diarrhea in Patients With HER2+ Early-Stage Breast Cancer.

Journal: Clinical breast cancer
Published: May 18, 2023

Role of Immunotherapy in Breast Cancer.

Role of Immunotherapy in Breast Cancer.

Journal: JCO oncology practice
Published: January 06, 2023

Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer.

Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer.

Journal: Breast (Edinburgh, Scotland)
Published: August 30, 2022

Circulating tumor cells, circulating tumor DNA, and disease characteristics in young women with metastatic breast cancer.

Circulating tumor cells, circulating tumor DNA, and disease characteristics in young women with metastatic breast cancer.

Journal: Breast cancer research and treatment
Published: January 05, 2021

Lung Cancer Survival in Patients With Autoimmune Disease.

Lung Cancer Survival in Patients With Autoimmune Disease.

Journal: JAMA network open
Published: December 14, 2020

The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer.

The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 17, 2020
Showing 1-12 of 20

Last Updated: 09/26/2026